跳至主要内容
临床试验/EUCTR2015-000519-42-IT
EUCTR2015-000519-42-IT进行中(未招募)1 期

Role of multimodal imaging in the evaluation of anatomic alterations in neovascular Age-Related Macular Degeneration (AMD) subjects: 18 monthPhase 2a open label study of Fovista¿ (anti-PDGF therapy) administered in combination with anti-VEGF therapy - OPH1008

IVERIC bio, Inc.0 个研究点目标入组 32 人开始时间: 2021年1月19日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
入组人数
32

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • OPHTHALMIC INCLUSION CRITERIA: The following inclusion criteria apply to the study eye:
  • - Best corrected visual acuity in the study eye between 20/40 and 20/200, inclusive. The VA must be re-confirmed at Day 1 prior to randomization.
  • Presence of Subfoveal CNV by FA or OCTA, or ICG or OCT (presence of fluid and hypereflective consistent with CNV).
  • GENERAL INCLUSION CRITERIA:
  • - Subjects of either gender aged =50 years.
  • - Women must agree to be using two forms of effective contraception, be post-menopausal for at least 12 months prior to trial entry, or surgically sterile; if of child-bearing potential, a serum pregnancy test must be performed within 14 days prior to the first injection with a negative result. The two forms of effective contraception must be implemented during the trial and for at least 60 days following the last dose of test medication.
  • - Provide written informed consent.
  • - Ability to comply with study and follow-up procedures and return for all trial visits.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 60
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 60

排除标准

  • OPHTHALMIC EXCLUSION CRITERIA:
  • - Subjects with atrophy or scar within 1 disc area (DA) of the center of the fovea are excluded.
  • - Prior thermal laser in the macular region, regardless of indication.
  • - Ocular or periocular infection in the past twelve (12) weeks.
  • - History of any of the following conditions or procedures in the study eye: rhegmatogenous retinal detachment, pars plana vitrectomy, filtering surgery (e.g. trabeculectomy), glaucoma drainage device, or corneal transplant.
  • - Previous therapeutic radiation in the region of the study eye.

研究者

相似试验

进行中(未招募)
1 期
Role of imaging in the evaluation of anatomic alterations in neovascular Age-Related Macular Degeneration (AMD) subjects: 18 month study of Fovista® (anti-PDGF therapy) administered in combination with anti-VEGF therapySubfoveal choroidal neovascularization secondary to Age-Related Macular Degeneration (AMD)MedDRA version: 18.0 Level: PT Classification code 10071129 Term: Neovascular age-related macular degeneration System Organ Class: 10015919 - Eye disordersMedDRA version: 18.0 Level: LLT Classification code 10067791 Term: Wet macular degeneration System Organ Class: 10015919 - Eye disorders
EUCTR2015-000519-42-FROPHTHOTECH CORPORATIO32
尚未招募
2 期
A Research Study to Evaluate the Effectiveness of a Novel Personalized Electrical Brain Stimulation for the Treatment of Drug-Resistant Focal Epilepsy
CTRI/2024/01/061978Dr. Suriya Prakash Muthukrishnan
进行中(未招募)
1 期
Prospektive Evaluation von Multimodality Imaging Verfahren (PET - CT - MRT - US - Bildfusion) bei malignen Tumoren der Kopf-Hals-RegioPatients with malignant Head and Neck Tumors - Diagnostic Imaging StudyMedDRA version: 9.1Level: LLTClassification code 10049516Term: Malignant tumor
EUCTR2007-004393-81-ATMedizinische Universität Innsbruck - Universitätsklinik für Radiodiagnostik (Radiologie I)270
招募中
不适用
The multimodarity imaging assesssment using MRI and US related to the associaton between the skeletal muscle and the liver.
JPRN-UMIN000009557niversity of Tsukuba70
尚未招募
1 期
The dislocation of Jaw Joint is assessed using special CT.
CTRI/2020/12/029529OGITHA SRI S
Phase 2a open label study of Fovista¿ (anti-PDGF... | 临床试验